SCHEMBL18159686

SCHEMBL18159686

Bc1ccc2c(c1)-c1ccccc1-c1cc(Br)ccc1O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.50
PTPRC P08575 1/20 0.43
SIRT1 Q96EB6 1/20 0.35
S100A4 P26447 1/20 0.35
CYP19A1 P11511 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
MAPK1 P28482 1/20 0.34
APP P05067 1/20 0.33
CYP2A6 P11509 1/20 0.32
HTR2A P28223 4/20 0.32
HTR2C P28335 4/20 0.32
DRD2 P14416 2/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2C P18825 1/20 0.32
DRD1 P21728 1/20 0.32
HTR7 P34969 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16800942 0.89 AHR (0.61) AHRPTPRCSIRT1S100A4CYP19A1
SCHEMBL18159685 0.85 MAPK1 (0.44) AHRTDP1CYP1A2MAPK1DRD2
SCHEMBL16800898 0.85 AHR (0.63) AHRPTPRCSIRT1S100A4CYP19A1
SCHEMBL16455012 0.83 AHR (0.65) AHRPTPRCSIRT1S100A4CYP19A1
SCHEMBL19885489 0.77 AHR (0.57) AHRPTPRCSIRT1S100A4CYP19A1
SCHEMBL10956695 0.76 AHR (0.57) AHRPTPRCSIRT1CYP19A1TDP1
SCHEMBL12959602 0.75 TGM2 (0.44) PTPRCS100A4
SCHEMBL17283693 0.70 MAPK1 (0.65) AHRPTPRCSIRT1L3MBTL1CYP1A2
SCHEMBL10952987 0.70 AHR (0.53) AHRPTPRCSIRT1CYP19A1TDP1
SCHEMBL13647592 0.69 S100A4 (0.75) PTPRCS100A4TDP1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 AHR 1161/4885PTPRC 1677/4885SIRT1 1491/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 AHR 1161/4885PTPRC 1677/4885SIRT1 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.